Startup profile for Leona Health: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Leona Health funding, valuation and investors

AI co-pilot for physicians on WhatsApp — practice management across Latin America.

Keep track of Leona Health

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Seed

$14M · December 2025

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$14M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

seed · Latin America

Investors in latest funding

Lead: Andreessen Horowitz

Other: General Catalyst

Sources: latest funding Last verified: 2026-07-25

Overview

Leona Health provides an AI co-pilot for physicians in Latin America that integrates with WhatsApp to structure patient conversations, manage appointments, and automate practice workflows. The company raised a $14M seed round in December 2025 led by Andreessen Horowitz Bio + Health, with General Catalyst (pre-seed lead) and Accel participating.

Why Leona Health is interesting

WhatsApp is the default patient channel in LatAm — Leona turns unstructured chats into clinical workflows without forcing doctors to change tools; a16z Bio + Health led a $14M seed in December 2025.

Product & use cases

Leona embeds in WhatsApp to capture patient messages, structure clinical notes, schedule appointments, send reminders, and automate routine practice admin — all within the messaging app doctors and patients already use.

  • Structuring WhatsApp patient chats into clinical records
  • Automated appointment scheduling and reminders
  • Practice admin automation for solo and small-group physicians
  • Patient follow-up and prescription refill coordination via WhatsApp

Key facts

  • Seed (Dec 2025): $14M led by a16z Bio + Health — PR Newswire
  • General Catalyst led pre-seed; Accel participated
  • WhatsApp-native AI for LatAm physicians

Funding history (newest first)

Investors in our directory

Funds linked from Leona Health's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: WhatsApp-native for LatAm where it is the default communication channel — no new app download for patients or doctors.

LatAm healthcare is WhatsApp-first. Leona's wedge is meeting providers where they work. Risk: WhatsApp/Meta policy changes and local health data regulations vary by country.

  • Doctoralia / Docplanner adjacent

    Appointment booking platforms in LatAm; less WhatsApp-native AI.

  • Local EMR systems incumbent

    Traditional practice software without messaging integration.

  • Nabla / Freed (US scribes) adjacent

    AI clinical documentation; not WhatsApp-focused or LatAm-specific.

Notable stories

  • Leona's December 2025 seed reflects a16z Bio + Health's thesis that LatAm healthcare AI must meet users on WhatsApp, not in standalone apps.

Industries

Healthtech AI & Machine Learning

Related funding articles

Venture Capital Tracker pieces that cover Leona Health's financing or category context.

FAQs about Leona Health

Practical answers founders, operators, and investors typically search for.

AI co-pilot for physicians in Latin America operating inside WhatsApp — appointments, clinical notes, and practice admin.
a16z Bio + Health (/fund/andreessen-horowitz) led $14M seed; General Catalyst (/fund/general-catalyst) led pre-seed.
Default patient communication channel across Latin America — no behavior change required.
December 2025 — $14M.
Leona augments WhatsApp workflow; traditional EMRs don't integrate with patient messaging.
Latin America focus — specific markets on leona.health.
Check leona.health leadership.
Must comply with local health data regulations per market.
Early stage — not disclosed.
Accel joined seed — not in VCT directory as lead.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.